Morning selling was to shake and scare off investors to sell their position. This baby is heading back up! Remember the FDA filing is for an orphan drug "Aplastic Anemia". Orphan drug companies go higher than other biotech stocks.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.